Literature DB >> 17724429

Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department.

Chien-Chang Lee1, Shey-Ying Chen, Chu-Lin Tsai, Shwu-Chong Wu, Wen-Chu Chiang, Jiun-Ling Wang, Hsin-Yun Sun, Shyr-Chyr Chen, Wen-Jone Chen, Po-Ren Hsueh.   

Abstract

The prognostic value of procalcitonin (PCT) in patients with sepsis at the emergency department (ED) has not been evaluated. We conducted a prospective observational study to compare the prognostic value of PCT on sepsis and compared with a validated score, Mortality in Emergency Department Sepsis (MEDS) score, and C-reactive protein (CRP) in the setting of ED of an urban, university-based medical center. Five hundred twenty-five consecutive adult patients admitted to the ED fulfilling the American College of Clinical Pharmacists/Society of Critical Care Medicine Consensus Conference definition of sepsis were prospectively enrolled. Serum PCT and CRP were evaluated for each patient. Clinical characteristics and laboratory results on ED admission were recorded using a standardized form. Each patient was followed for at least 30 days. The main outcome was early (5-day) and late (6- to 30-day) mortality. The median age of the study sample was 64.0 (interquartile range, 47-76) years old, and the overall 30-day mortality rate was 10.5%. The c-statistic in the prediction of early mortality was 0.89 for MEDS, 0.76 for PCT, and 0.68 for CRP. The c-statistic in the prediction of late mortality was 0.78 for MEDS, 0.70 for PCT, and 0.63 for CRP. Overall, MEDS score has the best discriminative capability among the three tested markers. Under the best cutoff value, PCT was the most sensitive, and MEDS score was the most specific marker. We suggest further combining the information on PCT and MEDS score to enhance the accuracy in predicting ED sepsis mortality.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17724429     DOI: 10.1097/shk.0b013e31815077ca

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  28 in total

1.  Direct bilirubin as a prognostic biomarker in enteric fistula patients complicated with sepsis: a case-control study.

Authors:  Yin Wu; Jianan Ren; Gefei Wang; Guosheng Gu; Bo Zhou; Chao Ding; Guanwei Li; Song Liu; Xiuwen Wu; Jun Chen; Jieshou Li
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  The rapidly expanding role of procalcitonin as a diagnostic and prognostic assay besides in UTIs.

Authors:  Shailendra Kapoor
Journal:  Int Urol Nephrol       Date:  2009-01-08       Impact factor: 2.370

3.  [Severe infections : causes and management of sepsis].

Authors:  B Salzberger; F Hanses; G Birkenfeld; J Langgartner
Journal:  Internist (Berl)       Date:  2013-08       Impact factor: 0.743

4.  Evaluation of community-acquired sepsis by PIRO system in the emergency department.

Authors:  Yun-Xia Chen; Chun-Sheng Li
Journal:  Intern Emerg Med       Date:  2013-06-16       Impact factor: 3.397

5.  Outcome prediction using clinical scores and biomarkers in patients with presumed severe infection in the emergency department.

Authors:  J Wilhelm; S Hettwer; D Hammer; M Schürmann; A Christoph; M Amoury; T Klöss; R Finke; H Ebelt; K Werdan
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-08-10       Impact factor: 0.840

6.  The impact of prior long-term versus short-term statin use on the mortality of bacteraemic patients.

Authors:  W Nseir; J Mograbi; J Khateeb; O Abu-Elheja; J Bishara; B Jihad; N Assy
Journal:  Infection       Date:  2011-09-06       Impact factor: 3.553

7.  Evaluation of the modified MEDS, MEWS score and Charlson comorbidity index in patients with community acquired sepsis in the emergency department.

Authors:  Ergün Çıldır; Mehtap Bulut; Halis Akalın; Egemen Kocabaş; Gökhan Ocakoğlu; Şule Akköse Aydın
Journal:  Intern Emerg Med       Date:  2012-12-19       Impact factor: 3.397

8.  Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis.

Authors:  Marcin F Osuchowski; Florin Craciun; Katrin M Weixelbaumer; Elizabeth R Duffy; Daniel G Remick
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

Review 9.  Role of biomarkers in sepsis care.

Authors:  Ravi S Samraj; Basilia Zingarelli; Hector R Wong
Journal:  Shock       Date:  2013-11       Impact factor: 3.454

10.  Plasma C-reactive protein levels are associated with improved outcome in ARDS.

Authors:  Ednan K Bajwa; Uzma A Khan; James L Januzzi; Michelle N Gong; B Taylor Thompson; David C Christiani
Journal:  Chest       Date:  2009-05-01       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.